GENENTECH ACTIVASE SALES UP 25% TO $48 MIL. IN FIRST QUARTER BUT PROTROPIN SALES FLAT: REVENUES CLIMB 22% TO $91.1 MIL; SQUIBB's CAPOTEN VOLUME IS $293 MIL.
• By The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
